Brought to you by:
Strength in numbers: Global VASCC COVID-19 project helps identify framework to tackle delayed cases
When Robert Cuff, MD, and Max Wohlauer, MD, first launched the Vascular Surgery COVID-19 Collaborative (VASCC) back in the spring of 2020, the pandemic was still in its first wave, and the goal of a new vascular surgery registry to…
FDA approves two pediatric venous thromboembolism indications for rivaroxaban
The Food and Drug Administration (FDA) has approved two pediatric indications for Xarelto (rivaroxaban): the treatment of venous thromboembolism (VTE) and reduction in the risk of recurrent VTE in patients from birth to less than 18 years after at least five days of…
Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical
Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company’s thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared device, the ReVene thrombectomy catheter. The ReVene mechanical thrombectomy catheter is specifically designed to remove large,…
Janssen submits new drug application to FDA for rivaroxaban to treat VTE in pediatric patients
The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced it has submitted a new drug application (NDA) to the Food and Drug Administration (FDA) for the use of Xarelto (rivaroxaban) in pediatric patients. The NDA seeks two pediatric indications: treatment…
Adjunctive compression to standard prophylaxis for postoperative VTE shows benefit in very high-risk patients
Among patients with a Caprini score of ≥11 who received standard prophylaxis for venous thromboembolism (VTE), adjunctive intermittent pneumatic compression (IPC) resulted in a significantly lower incidence of asymptomatic venous thrombosis. This is according to the findings of the IPC SUPER…
Vascular surgery COVID-19 registry participants probe state of practice amid winter surge
The question of the COVID-19 pandemic’s effect on vascular practice continues to occupy members of the specialty. Contributors to a global vascular surgery registry collecting data on its impact on scheduled operations and virus-related thrombotic complications detailed a series of…
AHA, ISTH release joint statement on future VTE research priorities
The American Heart Association (AHA) and the International Society on Thrombosis and Haemostasis (ISTH) issued a joint scientific statement July 8 outlining research priorities in the field of venous thromboembolism (VTE). “At the fundamental research level (T0), researchers need to…
Women are at a higher risk of iliac vein stent failure, VESS session hears
A recent study on iliac vein stenting showed lower long-term patency rates for women when compared to their male counterparts. The data were presented on June 24 at SVS ONLINE during the Vascular and Endovascular Surgical Society (VESS) session. Lead…
Special COVID-19 session added to SVS ONLINE slate
SVS ONLINE will now feature a session that hones in on the coronavirus pandemic, consisting of nine talks dealing with such issues as acute arterial thromboembolism, decreased vascular surgery emergencies and the management of central venous access. The special scientific…
AHA issues call to action to prevent VTE in hospitalised patients
Venous thromboembolism (VTE) is the leading cause of preventable hospital death in the U.S. and worldwide. A new policy statement from the American Heart Association (AHA) provides a focused review of VTE, risk scoring systems, preventive measures for the hospital…